Valued at $100.0M at its later-stage round, Sep 2025. Nothing has traded since.
- ·The complete investor list: 11 names
- ·Watch Reprieve Cardiovascular: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Reprieve Cardiovascular funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $30.9M | ▮ | ▮ |
| Sep 2024 | Debt | $9.5M | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $12.1M | ▮ | ▮ |
| Apr 2022 | Early Stage VC | $15.0M | ▮ | ▮ |
| Jul 2020 | Early Stage VC | $15.0M | ▮ | ▮ |
Membership and data by Private Market View
Reprieve Cardiovascular valuation
Reprieve Cardiovascular was valued at $100 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Reprieve Cardiovascular raised?
Reprieve Cardiovascular has raised $103 million across 5 recorded rounds since 2020. The largest was a $9.5 million debt round in Sep 2024; the most recent was a $30.9 million early-stage round in May 2025.
Reprieve Cardiovascular has filed 6 Form Ds with the SEC since 2020, most recently in Jun 2025 ($30.9 million sold to 12 investors).
How Reprieve Cardiovascular's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Reprieve Cardiovascular, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Reprieve Cardiovascular
- What is Reprieve Cardiovascular worth?
- Reprieve Cardiovascular is valued at $100.0M as of Oct 2026. Valued at $100.0M at its later-stage round, Sep 2025. Nothing has traded since.
- How much has Reprieve Cardiovascular raised?
- Reprieve Cardiovascular has raised $103.0M in total funding across 5 recorded rounds.
- When did Reprieve Cardiovascular last raise?
- Reprieve Cardiovascular last raised in May 2025 (Early Stage VC), raising $30.9M.